Cell Therapy

Top Story

Urinary microbiome variations associated with response to BCG therapy for bladder cancer

November 19, 2019

NIH selects five Lasker Clinical Research Scholars

November 16, 2019
The NIH selected five scientists as Lasker Clinical Research Scholars. The competitive program — part of a joint initiative with Albert and Mary Lasker Foundation…
Meeting NewsPerspective

Autologous antigen-loaded vaccine safe, feasible for neuroblastoma

November 9, 2019
NATIONAL HARBOR, Md. — An investigational vaccine of autologous dendritic cells loaded with autologous tumor antigens was safe and feasible as an adjuvant therapy…
Meeting News

Off-the-shelf natural killer cells safe, clinically active for advanced Merkel cell carcinoma

November 8, 2019
NATIONAL HARBOR, Md. — Allogeneic activated natural killer cell therapy resulted in some antitumor activity with no serious side effects in patients with…
More Headlines »

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

This activity is supported by an educational grant from Biotheranostics, Inc.

Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the…
More »
Meeting News

VIDEO: Early steroids may reduce severe side effects among patients who receive CAR T-cell therapy

July 13, 2019
More »

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »